There are no other tumor markers better than β-HCG and AFP for now, therefore determining an optimal cutoff of serum β-human chorionic gonadotropin for assisting the diagnosis of intracranial germinomas is clinical significant. This evidence concerns the gene AFP and brain germinoma.